Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine,and melphalan RIC HCT.
Saved in:
| Title: | Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine,and melphalan RIC HCT. |
|---|---|
| Authors: | Marsh, Rebecca A.1, Lane, Adam1, Mehta, Parinda A.1, Neumeier, Lisa1, Jodele, Sonata1, Davies, Stella M.1, Filipovich, Alexandra H.1 |
| Source: | Blood. 1/28/2016, Vol. 127 Issue 4, p503-512. 10p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00064971 |
|---|---|
| DOI: | 10.1182/blood-2015-07-659672 |
